How AI-powered automation enables fully automated cell culture
Friday, October 3, at 16:00 BST | 17:00 CEST | 11:00 EDT | 8:00 PDT
While cell-based models and assays are basic tools for drug development and biological research, tissue culture remains the most routine, hands-on, and time-consuming part of biological studies. Because of protocol complexity, sensitivity to errors, and substantial training requirements, these processes are difficult to automate and to ensure reproducibility and quality, especially when working with complex cell models such as organoids.
In this webinar, Dr. Oksana Sirenko from Molecular Devices, will present an overview of how AI-powered decision-making and automation create a fully automated cell culture platform. Discover how automation can not only alleviate these time-sensitive and highly routine tasks from the scientist, but can also reduce human error and inconsistencies associated with manual processes.
Key learning objectives:
- Explore how automated cell culture can lead to more reproducible assay outcomes
- Discover how automated, AI-powered decision making enables the creation of fully walkaway workflows
- Learn how complex cell models such as organoids, including brain organoids, and iPSCs can be cultured
Who should attend?
- Core facility leaders or managers.
- Researchers interested in scaling up their 3D biology workflows.
- Researchers working in high-throughput screening, high-content screening, or toxicology workflows.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Speakers
Dr. Oksana Sirenko is an established cell biologist and imaging specialist who is an expert in developing assays with complex cell-based models for research and drug discovery. She is a senior scientist at Molecular Devices, where she works on developing high-content imaging methods to analyze novel cell systems. Dr. Sirenko currently leads a group of scientists developing strategies and new tools for automating 3D cell models – including organoids and organ-on chips – for modeling cancer, neurotoxicity, and toxicology. Dr. Sirenko holds a Ph.D. in Biochemistry/Biophysics, has over 15 years of industry experience, and has authored more than 35 scientific papers.
Moderator
